Comparison of two different sampling intervals for optical coherence tomography evaluation of neointimal healing response after coronary stent implantation

Int J Cardiol. 2017 Jan 15:227:194-200. doi: 10.1016/j.ijcard.2016.11.173. Epub 2016 Nov 9.

Abstract

Background/objectives: Optical coherence tomography (OCT) is widely used for evaluation of healing response to stent implantation. We sought to test the agreement between the 1-mm and 0.6-mm sampling intervals for assessment of the percentage of uncovered and malapposed struts by OCT.

Methods: Thirty-eight patients presenting with acute coronary syndrome were randomized to receive either a titanium-nitride-oxide-coated stent (n=19) or an everolimus-eluting stent (n=19). Neointimal strut coverage and strut apposition were evaluated by OCT at 2-month follow-up. Two independent investigators performed offline OCT image analysis at 1-mm intervals. One investigator repeated the measurements at 0.6-mm intervals and measurements were compared between the two sampling intervals.

Results: At a median follow-up of 60 [8] days, 694 cross-sections (7603 struts) and 1138 cross-sections (12,331 struts) were analysed at 1-mm and at 0.6-mm intervals, respectively. The median [IQR] percentage of uncovered struts was 3.27% [11.1] versus 3.38% [9.76] (p=0.001), and the mean (±SD) percentage was 7.69±9.99% versus 6.27±8.14% (p=0.004), for the 1-mm sampling interval versus the 0.6-mm sampling interval analysis, respectively; the median percentage of malapposed struts was 0.42% [2.04] versus 0.12% [1.63], respectively, (p=0.003). The intraclass correlation coefficient between the two observers for the percentage of uncovered struts was 0.95.

Conclusions: The OCT-evaluated strut-level measurements of neointimal healing after stent implantation differ significantly between the 1-mm and the 0.6-mm sampling intervals.

Keywords: Malapposed struts; Neointimal healing; OCT; Sampling interval; Uncovered struts.

Publication types

  • Comparative Study
  • Multicenter Study
  • Randomized Controlled Trial

MeSH terms

  • Acute Coronary Syndrome / diagnostic imaging
  • Acute Coronary Syndrome / therapy*
  • Aged
  • Coronary Artery Disease / diagnostic imaging
  • Coronary Artery Disease / therapy
  • Drug-Eluting Stents*
  • Everolimus / pharmacology*
  • Female
  • Follow-Up Studies
  • Humans
  • Male
  • Middle Aged
  • Neointima / pathology
  • Observer Variation
  • Percutaneous Coronary Intervention / instrumentation*
  • Percutaneous Coronary Intervention / methods
  • Prospective Studies
  • Single-Blind Method
  • Statistics, Nonparametric
  • Time Factors
  • Titanium / pharmacology*
  • Tomography, Optical Coherence / methods*
  • Wound Healing / physiology

Substances

  • titanium-nitride-oxide
  • Everolimus
  • Titanium